These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 9504380

  • 1. Effects of quinapril, losartan and hydralazine on cardiac hypertrophy and beta-adrenergic neuroeffector mechanisms in transgenic (mREN2)27 rats.
    Zolk O, Flesch M, Schnabel P, Teisman AC, Pinto YM, van Gilst WH, Paul M, Böhm M.
    Br J Pharmacol; 1998 Feb; 123(3):405-12. PubMed ID: 9504380
    [Abstract] [Full Text] [Related]

  • 2. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
    Teisman AC, Pinto YM, Buikema H, Flesch M, Böhm M, Paul M, van Gilst WH.
    J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
    [Abstract] [Full Text] [Related]

  • 3. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
    Bohlender J, Hildenbrand U, Schlegel WP, Hempel P, Nissen E, Krause EG, Bartel S.
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
    [Abstract] [Full Text] [Related]

  • 4. Effects of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition on cardiac beta-adrenergic signal transduction.
    Böhm M, Zolk O, Flesch M, Schiffer F, Schnabel P, Stasch JP, Knorr A.
    Hypertension; 1998 Mar; 31(3):747-54. PubMed ID: 9495257
    [Abstract] [Full Text] [Related]

  • 5. Beta-adrenoceptor-linked signal transduction in ischemic-reperfused heart and scavenging of oxyradicals.
    Persad S, Takeda S, Panagia V, Dhalla NS.
    J Mol Cell Cardiol; 1997 Feb; 29(2):545-58. PubMed ID: 9140814
    [Abstract] [Full Text] [Related]

  • 6. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL, Seidler FJ, Slotkin TA.
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [Abstract] [Full Text] [Related]

  • 7. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
    Sethi R, Shao Q, Ren B, Saini HK, Takeda N, Dhalla NS.
    Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163
    [Abstract] [Full Text] [Related]

  • 8. Effects of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on beta-adrenoceptor signaling in heart failure produced by myocardial Infarction in rabbits: reversal of altered expression of beta-adrenoceptor kinase and G i alpha.
    Makino T, Hattori Y, Matsuda N, Onozuka H, Sakuma I, Kitabatake A.
    J Pharmacol Exp Ther; 2003 Jan; 304(1):370-9. PubMed ID: 12490614
    [Abstract] [Full Text] [Related]

  • 9. Functional activity and expression of the myocardial postreceptor adenylyl cyclase system in pressure overload hypertrophy in rat.
    Holmer SR, Bruckschlegel G, Schunkert H, Rataj DB, Kromer EP, Riegger GA.
    Cardiovasc Res; 1996 May; 31(5):719-28. PubMed ID: 8763401
    [Abstract] [Full Text] [Related]

  • 10. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 11. Chronic angiotensin II antagonism with losartan in one-kidney, one clip hypertensive rats: effect on cardiac hypertrophy, urinary sodium and water excretion and the natriuretic system.
    Garcia R, Bonhomme MC, Diebold S.
    J Hypertens; 1996 Jan; 14(1):81-9. PubMed ID: 12013499
    [Abstract] [Full Text] [Related]

  • 12. Modulation of adrenergic receptors during regression of cardiac hypertrophy.
    Matsui H, Makino N, Yano K, Nakanishi H, Hata T, Yanaga T.
    J Hypertens; 1994 Dec; 12(12):1353-7. PubMed ID: 7706693
    [Abstract] [Full Text] [Related]

  • 13. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    Nickenig G, Laufs U, Schnabel P, Knorr A, Paul M, Böhm MP.
    Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
    [Abstract] [Full Text] [Related]

  • 14. Vascular effects of COX inhibition and AT1 receptor blockade in transgenic rats harboring mouse renin-2 gene.
    Cheng ZJ, Tikkanen I, Vapaatalo H, Mervaala EM.
    J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):597-613. PubMed ID: 12512695
    [Abstract] [Full Text] [Related]

  • 15. Cardiovascular hypertrophy in one-kidney, one clip renal hypertensive rats: a role for angiotensin II?
    O'Sullivan JB, Black MJ, Bertram JF, Bobik A.
    J Hypertens; 1994 Oct; 12(10):1163-70. PubMed ID: 7836732
    [Abstract] [Full Text] [Related]

  • 16. The cardiac beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in monocrotaline-treated rats.
    Seyfarth T, Gerbershagen HP, Giessler C, Leineweber K, Heinroth-Hoffmann I, Pönicke K, Brodde OE.
    J Mol Cell Cardiol; 2000 Dec; 32(12):2315-26. PubMed ID: 11113007
    [Abstract] [Full Text] [Related]

  • 17. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
    Hu K, Gaudron P, Anders HJ, Weidemann F, Turschner O, Nahrendorf M, Ertl G.
    Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
    [Abstract] [Full Text] [Related]

  • 18. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
    Peiró C, Llergo JL, Angulo J, López-Novoa JM, Rodríguez-López A, Rodríguez-Mañas L, Sánchez-Ferrer CF.
    Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
    [Abstract] [Full Text] [Related]

  • 19. Beta-adrenergic signal transduction following carvedilol treatment in hypertensive cardiac hypertrophy.
    Böhm M, Ettelbrück S, Flesch M, van Gilst WH, Knorr A, Maack C, Pinto YM, Paul M, Teisman AC, Zolk O.
    Cardiovasc Res; 1998 Oct; 40(1):146-55. PubMed ID: 9876327
    [Abstract] [Full Text] [Related]

  • 20. Regulation of insulin-like growth factor-1 by the renin-angiotensin system during regression of cardiac eccentric hypertrophy through angiotensin-converting enzyme inhibitor and AT1 antagonist.
    Haddad GE, Blackwell K, Bikhazi A.
    Can J Physiol Pharmacol; 2003 Feb; 81(2):142-9. PubMed ID: 12710528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.